期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾胺酶与心血管疾病研究进展 被引量：2

Research progress with renalase and cardiovascular disease
下载PDF
导出
摘要 肾胺酶(renalase)是近年发现的一种由肾脏分泌的胺氧化酶,它可以通过降解儿茶酚胺来调节心功能与血压。肾脏分泌的激素与心血管疾病密切相关,肾胺酶作为反映心肾关系的新标志,具有降压、保护缺血心肌、改善心功能、降解儿茶酚胺等重要作用。 Renalase, a novel amine oxidase, is secreted by kidney. It regulates heart function and blood pressure by degrading catecholamines. Hormones secreted by the kidney are associated with cardiovascular disease. Renalase, as a new biomarker of heart and kidney functional correlation, can lower blood pressure, protect ischemic heart muscle, improve heart function and degrade catecholamine.
作者 郭运忠 蒋卫红
机构地区 中南大学湘雅三医院心血管内科
出处 《中南大学学报（医学版）》 CAS CSCD 北大核心 2012年第5期537-540,共4页 Journal of Central South University ：Medical Science
关键词 肾胺酶 高血压 心肌缺血 心功能不全 renalase hypertension myocardial ischemia cardiac dysfunction
分类号 R54 [医药卫生—心血管疾病]
  • 相关文献

参考文献21

  • 1Xu J, Li G, Wang P, et al. Renalase is a novel soluble monoamine oxidase that regulates cardiac function and blood pressure [J]. J Clin Invest, 2005,115( S): 1275-1280.
  • 2Hennebry SC, Eikelis N, Socratous F, et al. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves [J]. Mol Psychiatry, 2010,15 ( 3 ):234-236.
  • 3Li G, XuJ, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis ofrenalase[J]. Circulation, 2008,117(10): 1277-1282.
  • 4王锋,汪年松.renalase研究进展[J].中国中西医结合肾病杂志,2009,10(3):264-265. 被引量：2
  • 5Desir GV. Renalase is a novel renal hormone that regulates cardiovascular function[J].J Am Soc Hypertens, 2007,1(2):99-103.
  • 6Desir GV. Role of renalase in the regulation of blood pressure and the renal dopamine system[ J].Curr Opin Nephrol Hypertens, 2011,20(1):31-36.
  • 7Medvedev AE, Veselovsky AV, Fedchenko VI. Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: achievements and unsolved problems [ J]. Biochemistry (Mosc), 2010,75 (8):951-958.
  • 8Zhao O, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension:a two-stage association study in northern Hall Chinese population[ J].J Mol Med,2007,85(8):877-885.
  • 9Stec A, Semczuk A, Furmaga J, et al. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension[J]. Nephrol Dial Transplant, 2011, [Epub ahead of print].
  • 10Milani M, Ciriello F, Baroni S, et al.FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation[ J]. J Mol Biol,2011,411 (2):463-473.

二级参考文献35

  • 1王锋,汪年松.血压调节相关的肾内分泌学研究进展[J].中国临床医学,2005,12(4):562-563. 被引量：3
  • 2Santcs SF,Peixoto AJ. Hypertension in dialysis. Curr Opin Nephrol Hypertens,2005,14(2) : 111 - 1118.
  • 3Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infaction. N Engl J Med,2004,351 (13) : 1285 - 1295.
  • 4Go AS,Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovaxcular events, and hospitalization. N Engl J Med,2004,351(13) :1296 - 1305.
  • 5Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension,2004,43(4):699- 706.
  • 6Zoccali C, Mallamaci F, Tripepi G, et al. Norepinephrine and ooncentric hypertrophy in patients with end - stage renal disease. Hypertension, 2002,40(1) : 41 - 46.
  • 7Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end - stage renal disease. Circulation, 2002, 105 ( 11 ) : 1354- 1359.
  • 8Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end - stage renal disease. Circulation, 2002, 106 (15):1974 - 1979.
  • 9Zhao Q, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two - stage association study in northern Han Chinese population. J Mol Med, 2007,85 (8) .877 885.
  • 10Luft FC. Renalase, a catecholamine - metabolizing hormone from the kidney. Cell Metab, 2005,1 (6) : 358 - 360.

共引文献2

同被引文献45

  • 1Bhatti S,Hakeem A,Dillie KS. Prevalence,prognosis,and therapeutic implications of unrecognized left ventricular systolic dysfunction in patients with anemia and chronic kidney disease[J].{H}Congestive Heart Failure,2010,(6):271-277.
  • 2Jenkins K,Kirk M. Heart failure and chronic kidney disease:an integrated care approach[J].J Ren Care,2010,(Suppll):127-135.
  • 3Widmer F. Comorbidity in heart failure[J].{H}THERAPEUTISCHE UMSCHAU,2011,(2):103-106.
  • 4Shiba N,Shimokawa H. Chronic kidney disease and heart failure:Bidirectional close link and common therapeutic goal[J].{H}Journal of Cardiology,2011,(1):8-17.
  • 5Oka RK,De Marco T,Haskell WL. Impact of a home-based walking and resistance training program on quality of life in patients with heart failure[J].{H}American Journal of Cardiology,2000,(3):365-369.
  • 6Shlipak MG,Lash JP,Yang W. Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure[J].JCardFail,2011,(1):17-23.
  • 7McKelvie RS. Exercise training in patients with heart failure:clinical outcomes,safety,and indications[J].{H}Heart Failure Reviews,2008,(1):3-11.
  • 8Braith RW,Beck DT. Resistance exercise:training adaptations and developing a safe exercise prescription[J].{H}Heart Failure Reviews,2008,(1):69-79.
  • 9Hwang CL,Chien CL,Wu YT. Resistance training increases 6-minute walk distance in people with chronic heart failure:a systematic review[J].J Physiother,2010,(2):87-96.
  • 10Elahi M,Mahmood M,Shahbaz A. Current concepts underlying benefits of exercise training in congestive heart failure patients[J].Curt Cardiol Rev,2010,(2):104-111.

引证文献2

二级引证文献2

中南大学学报（医学版）
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部